RNN - Rexahn Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 560.91M
Enterprise Value 342.15M
Trailing P/E N/A
Forward P/E 1-3.49
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.62
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.58

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-43.25%
Return on Equity (ttm)-137.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.34M
Net Income Avi to Common (ttm)-22.23M
Diluted EPS (ttm)-0.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.2M
Total Cash Per Share (mrq)0.73
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.47
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-13.21M
Levered Free Cash Flow (ttm)-8.97M

Trading Information

Stock Price History

Beta 0.38
52-Week Change 31,193.33%
S&P500 52-Week Change 317.45%
52 Week High 34.74
52 Week Low 30.13
50-Day Moving Average 32.03
200-Day Moving Average 32.38

Share Statistics

Avg Vol (3 month) 3496.8k
Avg Vol (10 day) 3217.2k
Shares Outstanding 531.73M
Float 30.99M
% Held by Insiders 12.31%
% Held by Institutions 15.80%
Shares Short 32.21M
Short Ratio 33.26
Short % of Float 39.60%
Shares Short (prior month) 32.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3May 5, 2017